Poolbeg Pharma (POLB), a biopharmaceutical company, announces that, further to its announcement in July 2022, it has now received the initial results having completed the Lipopolysaccharide human challenge clinical trial
Trader’s Café with Zak Mir: A Week In Small Caps, Saturday 29th October 2022
Now that we have safely secured a new Prime Minister and the higher taxes which he previously delivered, the main focus is back to what to do with the consequences
Trader’s Café with Zak Mir: The Week In Small Caps
Back To The 70s
RNS Hotlist with Zak Mir: AAA, GENF, HFI, DBRG, ABDX, LEX, CMET, RENX, AGL, AQX, CNR, CHF, NCCL, ALL, UJO & GDR via Vox Markets
It is clear that most stock suspensions on the London market are unnecessary and usually the result of an overzealous regulator enjoying providing private investors with a deep hole in
Trader’s Cafe with Zak Mir: CTEA, PALM, RMM, BZT, GLR, KAV, POW, TYM, UKOG, SYM & & AQX via Vox Markets
Technology solutions provider Catenae Innovation (CTEA) said it had that it has signed a collaboration agreement with ProMake Limited, a specialist in material science and medical innovations.